Eleni Liapi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Eleni Liapi has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Aleah Marissa Holts
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA
1 shared publicationAna Mota
Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 17165 Stockholm, Sweden
1 shared publication- Anastassios Vourekas
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA
1 shared publication - Andor Pivarcsi
Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
1 shared publication - Anna Sapino
INOC - Istituto Nazionale Oncologico Candiolo; IRCCS, Candiolo, Italy
1 shared publication Aoxue Wang
Department of Dermatology, The Second Hospital of Dalian Medical University, 116023 Dalian, China
1 shared publication
Latest Publications
- Open Access
Human mascRNA interacts with SUMO E1 and reshapes nuclear SUMOylation
Human mascRNA is a tRNA-like 58-nucleotide non-coding RNA processed from the 3′ end of the MALAT1 transcript. Although mascRNA has been implicated in diverse cellular processes, its molecular mechanism has remained unclear. Here, we reveal a direct functional link between mascRNA and the SUMOylation pathway. Structural probing and SEC-SAXS confirm the compact, tRNA-like architecture of mascRNA in solution, while biochemical assays demonstrate its direct interaction with the SUMO E1 activating enzyme in vitro . Proteomic analyses show that mascRNA engages nuclear protein networks enriched for SUMOylated factors, including chromatin remodelers and nucleolar components. Transfection of synthetic mascRNA alters SAE2 and SUMO1 nuclear organization and broadly reduces nuclear SUMOylation, accompanied by decreased ProMyeLocytic (PML) body abundance and SUMO colocalization. SUMO1 immunoprecipitation and mass spectrometry reveal widespread decreases in SUMO conjugation, particularly among proteins involved in RNA metabolism and rRNA biogenesis with nuclear body localization. We further validate reduced SUMOylation of nucleolar factors such as BEND3 and ZNF106. These findings position mascRNA as a structured RNA ligand that modulates SUMO-dependent nuclear architecture and protein homeostasis, uncovering an unexpected intersection between RNA biology and post-translational modification networks. GRAPHICAL
Open AccessHuman mascRNA interacts with SUMO E1 and reshapes nuclear SUMOylation
Human mascRNA is a tRNA-like 58-nucleotide non-coding RNA processed from the 3′ end of the MALAT1 transcript. Although mascRNA has been implicated in diverse cellular processes, its molecular mechanism has remained unclear. Here, we reveal a direct functional link between mascRNA and the SUMOylation pathway. Structural probing and SEC-SAXS confirm the compact, tRNA-like architecture of mascRNA in solution, while biochemical assays demonstrate its direct interaction with the SUMO E1 activating enzyme in vitro . Proteomic analyses show that mascRNA engages nuclear protein networks enriched for SUMOylated factors, including chromatin remodelers and nucleolar components. Transfection of synthetic mascRNA alters SAE2 and SUMO1 nuclear organization and broadly reduces nuclear SUMOylation, accompanied by decreased ProMyeLocytic (PML) body abundance and SUMO colocalization. SUMO1 immunoprecipitation and mass spectrometry reveal widespread decreases in SUMO conjugation, particularly among proteins involved in RNA metabolism and rRNA biogenesis with nuclear body localization. We further validate reduced SUMOylation of nucleolar factors such as BEND3 and ZNF106. These findings position mascRNA as a structured RNA ligand that modulates SUMO-dependent nuclear architecture and protein homeostasis, uncovering an unexpected intersection between RNA biology and post-translational modification networks. GRAPHICAL
- Open Access
- 1 March 2020
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1867 (3) , 118465
tRNAs and tRNA fragments as modulators of cardiac and skeletal muscle function
- 1 March 2020
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1867 (3) , 118465
Open AccesstRNAs and tRNA fragments as modulators of cardiac and skeletal muscle function
- Open Access
- 24 April 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (19) , 9443-9452
Human skin long noncoding RNA WAKMAR1 regulates wound healing by enhancing keratinocyte migration
An increasing number of studies reveal the importance of long noncoding RNAs (lncRNAs) in gene expression control underlying many physiological and pathological processes. However, their role in skin wound healing remains poorly understood. Our study focused on a skin-specific lncRNA, LOC105372576, whose expression was increased during physiological wound healing. In human nonhealing wounds, however, its level was significantly lower compared with normal wounds under reepithelialization. We characterized LOC105372576 as a nuclear-localized, RNAPII-transcribed, and polyadenylated lncRNA. In keratinocytes, its expression was induced by TGF-β signaling. Knockdown of LOC105372576 and activation of its endogenous transcription, respectively, reduced and increased the motility of keratinocytes and reepithelialization of human ex vivo skin wounds. Therefore, LOC105372576 was termed “wound and keratinocyte migration-associated lncRNA 1” (WAKMAR1). Further study revealed that WAKMAR1 regulated a network of protein-coding genes important for cell migration, most of which were under the control of transcription factor E2F1. Mechanistically, WAKMAR1 enhanced E2F1 expression by interfering with E2F1 promoter methylation through the sequestration of DNA methyltransferases. Collectively, we have identified a lncRNA important for keratinocyte migration, whose deficiency may be involved in the pathogenesis of chronic wounds.
- 24 April 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (19) , 9443-9452
Open AccessHuman skin long noncoding RNA WAKMAR1 regulates wound healing by enhancing keratinocyte migration
An increasing number of studies reveal the importance of long noncoding RNAs (lncRNAs) in gene expression control underlying many physiological and pathological processes. However, their role in skin wound healing remains poorly understood. Our study focused on a skin-specific lncRNA, LOC105372576, whose expression was increased during physiological wound healing. In human nonhealing wounds, however, its level was significantly lower compared with normal wounds under reepithelialization. We characterized LOC105372576 as a nuclear-localized, RNAPII-transcribed, and polyadenylated lncRNA. In keratinocytes, its expression was induced by TGF-β signaling. Knockdown of LOC105372576 and activation of its endogenous transcription, respectively, reduced and increased the motility of keratinocytes and reepithelialization of human ex vivo skin wounds. Therefore, LOC105372576 was termed “wound and keratinocyte migration-associated lncRNA 1” (WAKMAR1). Further study revealed that WAKMAR1 regulated a network of protein-coding genes important for cell migration, most of which were under the control of transcription factor E2F1. Mechanistically, WAKMAR1 enhanced E2F1 expression by interfering with E2F1 promoter methylation through the sequestration of DNA methyltransferases. Collectively, we have identified a lncRNA important for keratinocyte migration, whose deficiency may be involved in the pathogenesis of chronic wounds.
- 1 December 2015
- Published by Elsevier in Forensic Science International: Genetics Supplement Series
- Vol. 5, e186-e188
Effect of RNA integrity on reference gene expression stability in human post-mortem wounded and normal skin
- 1 December 2015
- Published by Elsevier in Forensic Science International: Genetics Supplement Series
- Vol. 5, e186-e188
Effect of RNA integrity on reference gene expression stability in human post-mortem wounded and normal skin
- Open Access
- 22 March 2014
- Published by Wiley in Molecular Oncology
- Vol. 8 (5) , 912-926
Identification of novel non‐coding RNA‐based negative feedback regulating the expression of the oncogenic transcription factor GLI1
Non‐coding RNAs are a complex class of nucleic acids, with growing evidence supporting regulatory roles in gene expression. Here we identify a non‐coding RNA located head‐to‐head with the gene encoding the Glioma‐associated oncogene 1 (GLI1), a transcriptional effector of multiple cancer‐associated signaling pathways. The expression of this three‐exon GLI1 antisense (GLI1AS) RNA in cancer cells was concordant with GLI1 levels. siRNAs knockdown of GLI1AS up‐regulated GLI1 and increased cellular proliferation and tumor growth in a xenograft model system. Conversely, GLI1AS overexpression decreased the levels of GLI1, its target genes PTCH1 and PTCH2, and cellular proliferation. Additionally, we demonstrate that GLI1 knockdown reduced GLI1AS, while GLI1 overexpression increased GLI1AS, supporting the role of GLI1AS as a target gene of the GLI1 transcription factor. Activation of TGFβ and Hedgehog signaling, two known regulators of GLI1 expression, conferred a concordant up‐regulation of GLI1 and GLI1AS in cancer cells. Finally, analysis of the mechanism underlying the interplay between GLI1 and GLI1AS indicates that the non‐coding RNA elicits a local alteration of chromatin structure by increasing the silencing mark H3K27me3 and decreasing the recruitment of RNA polymerase II to this locus. Taken together, the data demonstrate the existence of a novel non‐coding RNA‐based negative feedback loop controlling GLI1 levels, thus expanding the repertoire of mechanisms regulating the expression of this oncogenic transcription factor.
- 22 March 2014
- Published by Wiley in Molecular Oncology
- Vol. 8 (5) , 912-926
Open AccessIdentification of novel non‐coding RNA‐based negative feedback regulating the expression of the oncogenic transcription factor GLI1
Non‐coding RNAs are a complex class of nucleic acids, with growing evidence supporting regulatory roles in gene expression. Here we identify a non‐coding RNA located head‐to‐head with the gene encoding the Glioma‐associated oncogene 1 (GLI1), a transcriptional effector of multiple cancer‐associated signaling pathways. The expression of this three‐exon GLI1 antisense (GLI1AS) RNA in cancer cells was concordant with GLI1 levels. siRNAs knockdown of GLI1AS up‐regulated GLI1 and increased cellular proliferation and tumor growth in a xenograft model system. Conversely, GLI1AS overexpression decreased the levels of GLI1, its target genes PTCH1 and PTCH2, and cellular proliferation. Additionally, we demonstrate that GLI1 knockdown reduced GLI1AS, while GLI1 overexpression increased GLI1AS, supporting the role of GLI1AS as a target gene of the GLI1 transcription factor. Activation of TGFβ and Hedgehog signaling, two known regulators of GLI1 expression, conferred a concordant up‐regulation of GLI1 and GLI1AS in cancer cells. Finally, analysis of the mechanism underlying the interplay between GLI1 and GLI1AS indicates that the non‐coding RNA elicits a local alteration of chromatin structure by increasing the silencing mark H3K27me3 and decreasing the recruitment of RNA polymerase II to this locus. Taken together, the data demonstrate the existence of a novel non‐coding RNA‐based negative feedback loop controlling GLI1 levels, thus expanding the repertoire of mechanisms regulating the expression of this oncogenic transcription factor.